David J. Duff Email & Phone Number

Montclair, New Jersey, United States

Small medical device company that developed and launched ground-breaking non-invasive neuromodulation device to treat and prevent migraine headaches. Spearheaded growth opportunities by identifying and pursuing potential areas for expansion, while collaboratively removing any obstacles hindering progress. Elevated HCP commercial strategies by enhancing promotional resources, developing patient education materials, managing conferences, and engaging key opinion leaders (KOLs). Facilitated implementation of new training. Streamlined internal processes by implementing new tools and procedures.• Recruited and trained entire Migraine Disease Speaker Bureau, consisting of Headache Specialist members, resulting in increased efficiency and productivity by eliminating expense of medical education company.

Summerfield, North Carolina, United States

Mid-sized pharmaceutical company that developed revolutionary sublingual thin filmstrip for immediate relief of OFF episode in Parkinson's Disease. Orchestrated participation of Movement Disorder experts in educational programs, advisory boards, posters, and publications, resulting in creation of multiple high-impact scientific papers and presentations. Played vital role in raising awareness of Parkinson's Disease and impact on motor activity by organizing disease state educational programs for patients and healthcare providers. • Developed and executed engaging Parkinson's Disease educational programs for healthcare providers and patients, reaching over 2K attendees. • Spearheaded recruitment of renowned Movement Disorder Specialists to speak at company-sponsored educational programs, resulting in 50% increase in attendance rates.• Contributed to successful development and launch of Sunovion's sublingual thin filmstrip for acute rescue of OFF motor symptoms in Parkinson's Disease patients, benefiting over one million people in U.S. and estimated four to six million people globally.

High Point, North Carolina

Founding member of a team that built a technology startup company focused on improving the health of Americans by making it easy to track food consumed. Find us at www.mealchecktech.com Read the press release from our partners at UNLV here: http://www.unlv.edu/news/release/unlv-teams-startup-bring-advanced-wearable-health-tracker-market.Read an article about the technology inventors that appeared in the Las Vegas Review-Journal here: http://www.reviewjournal.com/life/health/unlv-research-aims-offer-instant-snapshot-eating-habits

Greensboro/Winston-Salem, North Carolina Area

Mid-sized pharmaceutical company with Neuroscience and Aesthetics business units. Championed development and implementation of scientific communication materials for Neurosciences and Aesthetics Business Units, serving as subject-matter expert on products and disease states. Collaborated with renowned experts such as Kapil Sethi, MD, Mark Stacey, MD, and Virgilio Evidente, MD, to execute scientific communications and advisory boards. • Collaborated on scientific posters and publications with 100% of abstract authors in Neurosciences business unit.

Work collaboratively with internal Merz USA cross-functional teams and external strategic partners, to develop and execute strategic and tactical peer-to-peer education plans. • Curated non-accredited educational programs to successfully launch two brands, XEOMIN® and NAFTIN® 2% Cream.• Trained 100% of speakers for two different speaker bureaus, XEOMIN® and NAFTIN® 2% Cream.

Greensboro, North Carolina, United States

Managed development and execution of successful launch marketing strategy for XEOMIN®. • Led development of launch campaign for this new brand in company's portfolio.• Directed and oversaw all marketing research activities to inform successful strategy for XEOMIN®.

Newark, Delaware, United States

Established and maintained relationships with key opinion leaders in medical community. Collaborated with client marketing employees and ad agencies on development and implementation of marketing campaigns for new products. Recommended new strategies to improve patient compliance and adherence. Led cross-functional teams to successfully launch new marketing campaigns for clients’ products. • Led development of new marketing campaign for established brand in client’s portfolio.• Led development of launch campaign for new brand in client’s portfolio.

Engage clients for qualitative marketing research projects. Develop marketing campaign including sales pieces.

Philadelphia, Pennsylvania, United States

• Drove U.S. MYOBLOC sales to 50% increase 2005 vs. 2004; sales YTD 10/06 were 35% higher than 2005.• Led the development and execution of the MYOBLOC U.S. Marketing Plan.• Developed KOL supporters, medical education and e-promotions platform including the brand website. • A participating member of several critical teams: the MYOBLOC pricing strategy team, the NDC transition team, the commercial launch tracking team, and the international partner evaluation team.

• Led team of seven analytics professionals providing marketing research, forecasting, and promotion response insights to the Oncology brand teams.• Provided sales and marketing perspective to analytics team which in turn enabled them to provide analytics support which helped all 3 Oncology brand teams attain their forecasted sales.

Promoted in November 2001 to Brand Promotions Leader (manager/leader) of SEROQUEL (quetiapine fumarate) Brand Team, with 6 direct reports. • Guided growth of brand from $120 million/yr in sales to $1.64 billion/yr in sales during 5 years on the brand. • Responsible for leading the development and implementation of the communication strategy across professional promotions, medical education, KOL development, e-promotions, and managed care promotions, ensuring alignment with the overall strategy. • Managed $54 million advertising and promotions budget. Promoted in August 2000 to Senior Brand Manager after leading the repositioning of the brand.o Key accomplishments included conducting a strategic review of the brand in Q2 and Q3 2000 and subsequently repositioning the brand image and messages to drive growth. Conducted over a dozen advisory boards.Promoted in November 1999 to Associate Brand Manager, SEROUQEL after successful rotation in marketing research department.o Responsible for tactical implementation of brand strategy, including print pieces, med ed programs, and ad boards.Marketing Research Analyst – May 1998 – November 1999 • Promoted to first headquarters position from field sales. Responsible for design and execution of all primary marketing research projects for Prostate Cancer Portfolio (ZOLADEX® [goserelin] and CASODEX® [bicalutamide]) and SEROQUEL. • Managed qualitative and quantitative marketing research projects, including analysis of data and presentation of findings to product management teams. Psychiatric Care Representative – May 1997– May 1998 • Recruited by AstraZeneca to launch their new atypical anti-psychotic, SEROQUEL (quetiapine fumarate), in Los Angeles, CA territory. Promoted to Business & Marketing Research Department after leading district in non-retail market share during launch period (first 6 months on market).

Neuro-Psychiatric Specialist October 1995 – April 1997• Promoted to highly specialized sales force to call on most influential neurologists and psychiatrists in Los Angeles. Finished as #2 (out of 10 representatives) Psychiatric Specialist in Novartis’ Western Region in growth of CLOZARIL® (clozapine).Sales Representative – January 1988 – October 1995 • Top ELDEPRYL® (selegiline) sales rep (out of 10) in district and western region (out of 71), 1993.• Among top ten DYNACIRC® (isradipine) sales reps (out of 71) in western region, 1994.• Top PAMELOR® (nortriptyline) sales rep in Orange County, CA district in 1989.